$PALI
PALISADE BIO, INC.

2016 Q4 Form 10-K Financial Statement

#000117184317001704 Filed on March 23, 2017

View on sec.gov

Income Statement

Concept 2016 Q4 2015 Q4 2015
Revenue $10.00K $2.500K $10.42K
YoY Change 300.0% -46.42% -44.69%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.630M $1.600M $6.530M
YoY Change 1.88% -20.0% -27.2%
% of Gross Profit
Research & Development $4.030M $2.750M $12.64M
YoY Change 46.55% 7.42% 55.35%
% of Gross Profit
Depreciation & Amortization $60.00K $90.00K $148.0K
YoY Change -33.33% 0.0% 8.03%
% of Gross Profit
Operating Expenses $5.660M $4.350M $19.17M
YoY Change 30.11% -6.25% 9.81%
Operating Profit -$19.16M
YoY Change 9.87%
Interest Expense $270.0K -$420.0K $1.816M
YoY Change -164.29% 0.0% 12.06%
% of Operating Profit
Other Income/Expense, Net -$10.00K $10.00K -$1.747M
YoY Change -200.0% -66.35%
Pretax Income -$5.400M -$4.770M -$20.90M
YoY Change 13.21% -13.27% -7.64%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$5.400M -$4.770M -$20.90M
YoY Change 13.21% -13.32% -7.62%
Net Earnings / Revenue -54000.0% -190800.0% -200671.03%
Basic Earnings Per Share
Diluted Earnings Per Share -$67.50M -$79.50M -$348.3M
COMMON SHARES
Basic Shares Outstanding 91.79M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q4 2015 Q4 2015
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.19M $12.23M $12.23M
YoY Change 65.09% -55.58% -55.58%
Cash & Equivalents $15.19M $4.717M $4.720M
Short-Term Investments $5.000M $7.520M $7.520M
Other Short-Term Assets $650.0K $1.160M $1.160M
YoY Change -43.97% 182.93% 182.93%
Inventory
Prepaid Expenses $646.2K $1.160M
Receivables $10.49K $37.32K $40.00K
Other Receivables $50.00K $0.00 $0.00
Total Short-Term Assets $20.90M $13.43M $13.43M
YoY Change 55.64% -52.31% -52.31%
LONG-TERM ASSETS
Property, Plant & Equipment $269.6K $343.2K $340.0K
YoY Change -21.46% 13.92% 13.33%
Goodwill
YoY Change
Intangibles $990.2K $1.103M
YoY Change -10.27% -10.52%
Long-Term Investments
YoY Change
Other Assets $15.66K $71.80K $70.00K
YoY Change -78.19% 22.28% -53.33%
Total Long-Term Assets $1.700M $1.518M $1.520M
YoY Change 11.93% -9.74% -9.52%
TOTAL ASSETS
Total Short-Term Assets $20.90M $13.43M $13.43M
Total Long-Term Assets $1.700M $1.518M $1.520M
Total Assets $22.60M $14.95M $14.95M
YoY Change 51.2% -49.91% -49.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.340M $1.460M $1.460M
YoY Change 60.27% -41.6% -41.6%
Accrued Expenses $850.0K $160.0K $160.0K
YoY Change 431.25% -75.38% -75.38%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.706M $4.545M $4.550M
YoY Change -18.47% 522.62% 523.29%
Total Short-Term Liabilities $7.333M $6.425M $6.430M
YoY Change 14.13% 60.29% 60.35%
LONG-TERM LIABILITIES
Long-Term Debt $3.383M $3.380M
YoY Change -58.01% -58.06%
Other Long-Term Liabilities $3.940M $170.0K $170.0K
YoY Change 2217.65% 183.33% 183.33%
Total Long-Term Liabilities $0.00 $3.383M $3.550M
YoY Change -100.0% -58.01% -56.28%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.333M $6.425M $6.430M
Total Long-Term Liabilities $0.00 $3.383M $3.550M
Total Liabilities $11.27M $9.982M $9.980M
YoY Change 12.94% -17.67% -17.66%
SHAREHOLDERS EQUITY
Retained Earnings -$193.0M -$172.0M
YoY Change 12.26% 13.84%
Common Stock $110.3K $70.77K
YoY Change 55.89% -91.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.33M $4.967M $4.970M
YoY Change
Total Liabilities & Shareholders Equity $22.60M $14.95M $14.95M
YoY Change 51.2% -49.91% -49.9%

Cashflow Statement

Concept 2016 Q4 2015 Q4 2015
OPERATING ACTIVITIES
Net Income -$5.400M -$4.770M -$20.90M
YoY Change 13.21% -13.32% -7.62%
Depreciation, Depletion And Amortization $60.00K $90.00K $148.0K
YoY Change -33.33% 0.0% 8.03%
Cash From Operating Activities -$4.080M -$3.900M -$18.93M
YoY Change 4.62% 12.07% 61.66%
INVESTING ACTIVITIES
Capital Expenditures -$30.00K -$50.00K $176.3K
YoY Change -40.0% -37.5% -15.21%
Acquisitions
YoY Change
Other Investing Activities -$5.000M -$2.500M $7.490M
YoY Change 100.0% -149.9%
Cash From Investing Activities -$5.030M -$2.550M $7.250M
YoY Change 97.25% 3542.86% -146.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.932M
YoY Change
Debt Paid & Issued, Net $1.154M
YoY Change -40.18%
Cash From Financing Activities 18.63M -1.960M 3.890M
YoY Change -1050.51% -147.46% -83.04%
NET CHANGE
Cash From Operating Activities -4.080M -3.900M -18.93M
Cash From Investing Activities -5.030M -2.550M 7.250M
Cash From Financing Activities 18.63M -1.960M 3.890M
Net Change In Cash 9.520M -8.410M -7.790M
YoY Change -213.2% -1550.0% 79.91%
FREE CASH FLOW
Cash From Operating Activities -$4.080M -$3.900M -$18.93M
Capital Expenditures -$30.00K -$50.00K $176.3K
Free Cash Flow -$4.050M -$3.850M -$19.11M
YoY Change 5.19% 13.24% 60.32%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q4 cur Accounts Payable And Accrued Expenses Excluding Accrued Bonuses
AccountsPayableAndAccruedExpensesExcludingAccruedBonuses
2343936
CY2015Q4 cur Accounts Payable And Accrued Expenses Excluding Accrued Bonuses
AccountsPayableAndAccruedExpensesExcludingAccruedBonuses
1455826
CY2015 cur Cashless And Partial Cashless Exercises Price For Warrants And Options
CashlessAndPartialCashlessExercisesPriceForWarrantsAndOptions
8
CY2015 cur Class Of Warrant Or Right Exercised During Period Exercise Price
ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice
25.22
CY2016 cur Expenses Related To Issuance Of Derivative Instrument
ExpensesRelatedToIssuanceOfDerivativeInstrument
466541
CY2015 cur Expenses Related To Issuance Of Derivative Instrument
ExpensesRelatedToIssuanceOfDerivativeInstrument
CY2016 cur Fees Related To Issuance Of Derivative Instrument And Other Expenses
FeesRelatedToIssuanceOfDerivativeInstrumentAndOtherExpenses
474167
CY2015 cur Fees Related To Issuance Of Derivative Instrument And Other Expenses
FeesRelatedToIssuanceOfDerivativeInstrumentAndOtherExpenses
716
CY2016 cur Nonoperating Gains Losses Related Party Settlement
NonoperatingGainsLossesRelatedPartySettlement
458608
CY2015 cur Nonoperating Gains Losses Related Party Settlement
NonoperatingGainsLossesRelatedPartySettlement
CY2016 dei Amendment Flag
AmendmentFlag
false
CY2016 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2016 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016 dei Document Period End Date
DocumentPeriodEndDate
2016-12-31
CY2016 dei Document Type
DocumentType
10-K
CY2016Q2 dei Entity Public Float
EntityPublicFloat
30672818
CY2015 cur Number Of Warrants And Options Exercised
NumberOfWarrantsAndOptionsExercised
169923
CY2015 cur Number Of Warrants Options And Rs Us Forfeited
NumberOfWarrantsOptionsAndRSUsForfeited
94998
CY2016Q4 cur Operating Leases Future Minimum Payments Due After Four Years
OperatingLeasesFutureMinimumPaymentsDueAfterFourYears
CY2016 cur Payment Of Employee Taxes On Stock Option Exercise
PaymentOfEmployeeTaxesOnStockOptionExercise
CY2015 cur Payment Of Employee Taxes On Stock Option Exercise
PaymentOfEmployeeTaxesOnStockOptionExercise
802054
CY2015 cur Proceeds From Exercise Of Stock Purchase Warrants Net Of Issuance Costs
ProceedsFromExerciseOfStockPurchaseWarrantsNetOfIssuanceCosts
3073535
CY2016 cur Proceeds From Exercise Of Stock Purchase Warrants Net Of Issuance Costs
ProceedsFromExerciseOfStockPurchaseWarrantsNetOfIssuanceCosts
CY2015 cur Proceeds From Exercise Of Warrants And Options And Conversion Of Rs Us
ProceedsFromExerciseOfWarrantsAndOptionsAndConversionOfRSUs
0
CY2016Q2 cur Proceeds From Issuance Or Sale Of Equity Net Of Issuance Costs
ProceedsFromIssuanceOrSaleOfEquityNetOfIssuanceCosts
7229000
CY2016 cur Proceeds From Issuance Or Sale Of Equity Net Of Issuance Costs
ProceedsFromIssuanceOrSaleOfEquityNetOfIssuanceCosts
28118962
CY2015 cur Proceeds From Issuance Or Sale Of Equity Net Of Issuance Costs
ProceedsFromIssuanceOrSaleOfEquityNetOfIssuanceCosts
2931924
CY2016 cur Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageGrantDateFairValue
22.96
CY2015Q4 cur Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedNumber
11615
CY2016Q4 cur Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedNumber
6863
CY2016Q4 cur Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Exercisable Number
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber
6863
CY2016Q4 cur Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageGrantDateFairValue
30.70
CY2015Q4 cur Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Vested And Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValue
27.69
CY2016Q4 cur Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Vested And Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndNonvestedWeightedAverageGrantDateFairValue
30.70
CY2016 cur Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm
CY2015 cur Stock And Warrants Issued During Period From Capital Raises Value Net
StockAndWarrantsIssuedDuringPeriodFromCapitalRaisesValueNet
2931924
CY2016 cur Stock And Warrants Issued During Period From Capital Raises Value Net
StockAndWarrantsIssuedDuringPeriodFromCapitalRaisesValueNet
23991738
CY2015 cur Stock Issued During Period Shares Cashless Exercise Of Warrants And Options And Conversion Of Rs Us
StockIssuedDuringPeriodSharesCashlessExerciseOfWarrantsAndOptionsAndConversionOfRSUs
97723
CY2015 cur Stock Issued During Period Shares Warrants Exercised
StockIssuedDuringPeriodSharesWarrantsExercised
131185
CY2015 cur Stock Issued During Period Value From Warrants Exercised
StockIssuedDuringPeriodValueFromWarrantsExercised
3073535
CY2015 cur Stock Issued During Period Value Rsu And Option Exercises Net Of Forfeitures
StockIssuedDuringPeriodValueRSUAndOptionExercisesNetOfForfeitures
-802054
CY2016Q2 cur Warrants Expiration Period
WarrantsExpirationPeriod
P5Y
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10491
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
37316
CY2016Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
852963
CY2015Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
161362
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
724771
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
628551
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3905
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3071
CY2016 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P8Y182D
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
204239837
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
176852115
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2951367
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3445539
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3445539
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2951367
CY2016 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
347491
CY2015 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
870530
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
176000
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
197000
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8.7
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2.8
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2016Q4 us-gaap Assets
Assets
22604328
CY2015Q4 us-gaap Assets
Assets
14949548
CY2016Q4 us-gaap Assets Current
AssetsCurrent
20904716
CY2015Q4 us-gaap Assets Current
AssetsCurrent
13431084
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4716533
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12518980
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15194949
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
10478416
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-7802447
CY2016Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
20200000
CY2016Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
5.20
CY2016Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
3.25
CY2016Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11032858
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7077362
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11032858
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7077362
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
110329
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
70774
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
55932114
CY2016Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
51249822
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
39555984
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
1373979
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21073777
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20906830
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2016 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2015 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-5626995
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-6645222
CY2016 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2015 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6810088
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-7600737
CY2016 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
6810088
CY2015 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
7600737
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1183093
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-955515
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
62742202
CY2015Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
5717023
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
10118401
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
10659107
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
62742202
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
55932114
CY2016 us-gaap Depreciation
Depreciation
161000
CY2015 us-gaap Depreciation
Depreciation
148000
CY2016 us-gaap Depreciation And Amortization
DepreciationAndAmortization
337508
CY2015 us-gaap Depreciation And Amortization
DepreciationAndAmortization
345460
CY2016 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
660253
CY2015 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
CY2016Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
3921917
CY2015Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
CY2016Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
53081
CY2015Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
CY2016Q4 us-gaap Due From Related Parties Noncurrent
DueFromRelatedPartiesNoncurrent
424240
CY2015Q4 us-gaap Due From Related Parties Noncurrent
DueFromRelatedPartiesNoncurrent
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.53
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.99
CY2015 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
CY2016 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-543
CY2015 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-4409
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.332
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.369
CY2016 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.076
CY2015 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.005
CY2016 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.026
CY2015 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.009
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.042
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.043
CY2016Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2247000
CY2016 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2015 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2016 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-660253
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
960670
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
784331
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
96000
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
96000
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
96000
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
96000
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
96000
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1950823
CY2015Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1887798
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
990153
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1103467
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
990153
CY2016 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-10284
CY2015 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7497202
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6529667
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2016 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2015 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
879076
CY2015 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1045765
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-26825
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-188208
CY2016 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
691601
CY2015 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-485598
CY2016 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
477321
CY2015 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
CY2016 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-21672
CY2015 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
253427
CY2016 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-55663
CY2015 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
13998
CY2016 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-155935
CY2015 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-250624
CY2016 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-513156
CY2015 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
840772
CY2016 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
63026
CY2015 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
67312
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1103467
CY2016 us-gaap Interest Expense
InterestExpense
1141297
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-18931666
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-20903901
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-21074611
CY2015 us-gaap Interest Expense
InterestExpense
1816206
CY2016 us-gaap Interest Paid
InterestPaid
990857
CY2015 us-gaap Interest Paid
InterestPaid
954746
CY2016 us-gaap Investment Income Interest
InvestmentIncomeInterest
58835
CY2015 us-gaap Investment Income Interest
InvestmentIncomeInterest
69549
CY2016 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
243000
CY2015 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
318000
CY2016Q4 us-gaap Liabilities
Liabilities
11273550
CY2015Q4 us-gaap Liabilities
Liabilities
9982270
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22604328
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14949548
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7333424
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6425472
CY2016Q4 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
18209
CY2015Q4 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
174144
CY2016Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3705787
CY2015Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
4545180
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3382654
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
23738728
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3887187
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
2356339
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
7246441
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-15616108
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-437768
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1747373
CY2016 us-gaap Operating Expenses
OperatingExpenses
20653089
CY2015 us-gaap Operating Expenses
OperatingExpenses
19166945
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-20636843
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-19156528
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
513613
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
244227
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
97132
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
172254
CY2016Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
133600000
CY2015Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
116300000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
15662
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
71797
CY2015 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2929
CY2016 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
834
CY2016 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
834
CY2015 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2929
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
430738
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
263104
CY2016 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
CY2015 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
45000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
98088
CY2016 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
5000000
CY2015 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
15007478
CY2016 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
313483
CY2015 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
7517453
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
176272
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
10000
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2016Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
646195
CY2015Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1159782
CY2016 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><div style="display: inline; text-decoration: underline;">Reclassification of Prior Year Presentation </div></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain prior year amounts have been reclassified for consistency with the current period presentation. These reclassifications had no material effect on the reported results of operations.</div></div></div></div></div>
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2932000
CY2016Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
8000000
CY2016 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
7517453
CY2015 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
994328
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
971751
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
269557
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
343200
CY2016 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
4569540
CY2015 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1154150
CY2016 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
124177
CY2015 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
117068
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13155887
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12637278
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-193033293
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-171958682
CY2016 us-gaap Revenues
Revenues
16246
CY2015 us-gaap Revenues
Revenues
10417
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
3445539
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
2951367
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
502
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
26.26
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0139
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
4250
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
5100000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1303198
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
26.42
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y36D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y36D
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
60026
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
436347
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.18
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
24.57
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
550000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1315666
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1691987
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
27.09
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
22.60
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1685187
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
22.67
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
14.05
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.91
CY2016Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
1691987
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y36D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2643000
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2215000
CY2016Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
22.60
CY2015Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
49.01
CY2016Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
5.20
CY2016Q4 us-gaap Short Term Investments
ShortTermInvestments
5000000
CY2015Q4 us-gaap Short Term Investments
ShortTermInvestments
7517453
CY2016 us-gaap Stock Issued1
StockIssued1
8936
CY2015 us-gaap Stock Issued1
StockIssued1
1981945
CY2015 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
62494
CY2016Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1538462
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
17719336
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
4967278
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
11330778
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><div style="display: inline; background-color: white"><div style="display: inline; text-decoration: underline;">Use of Estimates</div></div></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><div style="display: inline; background-color: white">The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The consolidated financial statements include significant estimates for the expected economic life and value of our licensed technology, our net operating loss carry forward and related valuation allowance for tax purposes and our stock-based compensation related to employees and directors, consultants and advisors, among other things. Because of the use of estimates inherent in the financial reporting process, actual results could differ significantly from those estimates.</div></div></div></div></div></div>
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8345992
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6989764

Files In Submission

Name View Source Status
0001171843-17-001704-index-headers.html Edgar Link pending
0001171843-17-001704-index.html Edgar Link pending
0001171843-17-001704.txt Edgar Link pending
0001171843-17-001704-xbrl.zip Edgar Link pending
chart2.jpg Edgar Link pending
chart3.jpg Edgar Link pending
chartb.jpg Edgar Link pending
cur-20161231.xml Edgar Link completed
cur-20161231.xsd Edgar Link pending
cur-20161231_cal.xml Edgar Link unprocessable
cur-20161231_def.xml Edgar Link unprocessable
cur-20161231_lab.xml Edgar Link unprocessable
cur-20161231_pre.xml Edgar Link unprocessable
exh_2301.htm Edgar Link pending
exh_2302.htm Edgar Link pending
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_321.htm Edgar Link pending
exh_322.htm Edgar Link pending
f10k_031617p.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending